Clinical Trial Update: Azithromycin Reduction to Reach Elimination of Trachoma B [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating azithromycin for eliminating Trachoma (Trachoma B) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trachoma

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Trachoma | Phase 4 | Status: WITHDRAWN